It is thought to be caused by a combination of genetic and environmental factors.Treatment of acute symptoms is usually with an inhaled short-acting beta-2 agonist (such as salbutamol).Symptoms can be prevented by avoiding triggers, such as allergens and irritants, and by inhaling corticosteroids. Leukotriene antagonists are less effective than corticosteroids and thus less preferred.
In this special issue, we intend to invite front-line researchers and authors to submit original research and review articles on exploring Asthma.
Authors should read over the journal’s Authors' Guidelines carefully before submission, Prospective authors should submit an electronic copy of their complete manuscript through the journal Paper Submission System.
Please kindly notice that the “Special Issue’’ under your manuscript title is supposed to be specified and the research field “Special Issue-Asthma research” should be chosen during your submission.
According to the following timetable:
January 10th, 2013
Prof. James J. Chou
Harvard Medical School, USA
For further questions or inquiries
Please contact Editorial Assistant at